HOME Top Market Reports Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021

Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: January 2017
Report Code: BT 2776

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global glycomics/glycobiology market is expected to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, at a CAGR of 13.3%. The market is segmented based on product, application, end user, and region.

On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. The enzyme segment is projected to grow at the highest CAGR during the forecast period. This growth is mainly attributed to their consumable nature and wide applications in a variety of R&D and drug discovery procedures.

On the basis of type, the glycomics instruments market is segmented into antibody arrays, HPLC, lectin arrays, MALDI-TOF, mass spectrometers, and other glycomics instruments. In 2016, the mass spectrometers segment is expected to account for the largest share of the glycomics instruments market. This growth can be attributed to the variety of applications and its importance in the glycomics R&D processes.

On the basis of end user, the market is segmented into academic research institutes, pharmaceutical & biotechnology companies, and contract research organizations. The academic research institutes segment is expected to account for the largest share of the market in 2016. This growth is attributed to rising availability of funding for life science research.

Geographically, the glycomics market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the Asia segment is primarily driven by the increasing demand for the personalized medicine and commercialization of pharmaceutical and biotechnology research.

Major players in the glycomics market are Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).

Target Audience for this Report:

  • Glycomics enzymes, kits, reagents, and instruments manufacturers and vendors
  • Associations related to glycomics enzymes, kits, and reagents
  • Research institutes and contract research organizations (CROs)
  • Market research and consulting firms
  • Life sciences instrumentation and reagent companies
  • Pharmaceutical and biotechnology companies
  • Clinical research institutes

Value Addition for the Buyer:

This report aims to provide insights on the global glycomics market.

It provides value information for the various types of enzymes, instruments, kits, and reagent used in the glycobiology market. Furthermore, the value information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

The above-mentioned information would benefit the buyer by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize the growth opportunities.

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This report categorizes the Glycobiology market into the following segments:

Glycomics Market, by Product

  • Enzymes
    • Glycosidases
    • Glycosyltransferases
    • Neuraminidases
    • Sialyltransferases
    • Other Enzymes
  • Instruments
    • Antibody Arrays
    • HPLC
    • Lectin Arrays
    • MALDI-TOF
    • Mass Spectrometers
    • Other Glycomics Instruments
  • Kits
    • Glycan Labeling Kits
    • Glycan Purification Kits
    • Glycan Release Kits
    • Other Kits
  • Reagents
    • Glycoproteins
    • Monosaccharides
    • Oligosaccharides
    • Other Reagents

Glycomics Market, by Application

  • Diagnostics
  • Drug Discovery & Development
  • Oncology
  • Immunology
  • Other Applications

Glycomics Market, by End User

  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations

Glycomics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • RoE
  • Asia
    • Japan
    • China
    • India
    • Rest of Asia (RoA)
  • Rest of the World (RoW)
    • South America
    • Middle East and Africa
    • Pacific and Oceania

Customization Options:

Company Information: Detailed company profiles of five more market players

Product Portfolio Assessment: Detailed comparison of the product portfolios of the top five companies

Investment Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Markets Definition
    1.3 Markets Covered
           1.3.1 Years Considered for the Study
    1.4 Currency
    1.5 Market Scope
    1.6 Market Stakeholders

2 Research Methodology (Page No. - 16)
    2.1 Glycomics Market Size Estimation
    2.2 Glycomics Market Breakdown and Data Triangulation
    2.3 Glycomics Market Share Estimation
           2.3.1 Key Data From Secondary Sources
           2.3.2 Key Data From Primary Sources
           2.3.3 Assumptions for the Study

3 Executive Summary (Page No. - 23)

4 Premium Insights (Page No. - 28)
    4.1 Glycomics: Market Overview (2016-2021)
    4.2 Geographic Analysis: Glycomics Market, By Product
    4.3 Life Cycle Analysis, By Region

5 Market Overview (Page No. - 31)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                     5.2.1.1 Increase in Funding for Proteomics and Glycomics Research, Growing R&D Expenditure
                     5.2.1.1 Growth of the Proteomics Market
                     5.2.1.2 Technological Advancements in Glycomics Instrumentation
           5.2.2 Restraints
                     5.2.2.1 High Degree of Consolidation Hinders Entry of New Players to the Market
                     5.2.2.2 Stringent Regulatory Frameworks and Time-Consuming Approval Processes
           5.2.3 Opportunities
                     5.2.3.1 Increased Use of Personalized Medicine
                     5.2.3.2 Biomarker Identification
                     5.2.3.3 Developing Countries and Emerging Markets
           5.2.4 Challenges
                     5.2.4.1 High Costs of Tools & Instruments and Their Maintenance

6 Glycomics Market, By Product (Page No. - 37)
    6.1 Introduction
    6.2 Enzymes
           6.2.1 Glycosidases
           6.2.2 Glycosyltransferases
           6.2.3 Neuraminidases
           6.2.4 Sialyltransferases
           6.2.5 Other Glycomics Enzymes
    6.3 Instruments
           6.3.1 Antibody Arrays
           6.3.2 HPLC
           6.3.3 Lectin Arrays
           6.3.4 MALDI-TOF
           6.3.5 Mass Spectrometers
           6.3.6 Other Glycomics Instruments
    6.4 Kits
           6.4.1 Glycan Labeling Kits
           6.4.2 Glycan Purification Kits
           6.4.3 Glycan Release Kits
           6.4.4 Other Glycomics Kits
    6.5 Reagents
           6.5.1 Glycoproteins
           6.5.2 Monosaccharides
           6.5.3 Oligosaccharides
           6.5.4 Other Reagents

7 Glycomics Market, By Application (Page No. - 58)
    7.1 Introduction
    7.2 Diagnostics
    7.3 Drug Discovery & Development
    7.4 Oncology
    7.5 Immunology
    7.6 Other Applications

8 Glycomics Market, By End User (Page No. - 67)
    8.1 Introduction
    8.2 Academic Research Institutes
    8.3 Pharmaceutical & Biotechnology Companies
    8.4 Contract Research Organizations

9 Glycomics Market, By Region (Page No. - 73)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 France
           9.3.3 U.K.
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 RoE
    9.4 Asia
           9.4.1 China
           9.4.2 Japan
           9.4.3 India
           9.4.4 Rest of Asia
    9.5 Rest of the World (RoW)
           9.5.1 South America
           9.5.2 Middle East and Africa
           9.5.3 Pacific and Oceania

10 Competitive Landscape (Page No. - 109)
     10.1 Overview
     10.2 Market Share Analysis
               10.2.1 Glycomics Enzymes, Kits, and Regents
               10.2.2 Glycomics Instruments
     10.3 Competitive Situation and Trends
               10.3.1 Product Launches
               10.3.2 Expansions
               10.3.3 Agreements
               10.3.4 Acquisitions, Collaborations, Approvals, and Others

11 Company Profiles (Page No. - 118)
(Overview, Products and Services, Financials, Strategy & Development)*
     11.1 Introduction
     11.2 Merck KGaA
     11.3 Takara Bio, Inc.
     11.4 Shimadzu Corporation
     11.5 Bruker Corporation
     11.6 Waters Corporation
     11.7 New England Biolabs Inc.
     11.8 Agilent Technologies, Inc.
     11.9 Danaher Corporation
     11.10 ProZyme, Inc.
     11.11 Thermo Fisher Scientific, Inc.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 149)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports
     12.7 Author Details


List of Tables (91 Tables)

Table 1 Glycomics Market Summary
Table 2 Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 3 Glycomics Enzymes Market Size, By Product, 2014–2021 (USD Million)
Table 4 Glycomics Enzymes Market Size, By Region, 2014-2021 (USD Million)
Table 5 Glycosidases Market Size, By Region, 2014-2021 (USD Million)
Table 6 Glycosyltransferases Market Size, By Region, 2014-2021 (USD Million)
Table 7 Neuraminidases Market Size, By Region, 2014-2021 (USD Million)
Table 8 Sialyltransferases Market Size, By Region, 2014–2021 (USD Million)
Table 9 Other Glycomics Enzymes Market Size, By Region, 2014–2021 (USD Million)
Table 10 Glycomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 11 Glycomics Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 12 Antibody Arrays Market Size, By Region, 2014–2021 (USD Million)
Table 13 HPLC Market Size, By Region, 2014–2021 (USD Million)
Table 14 Lectin Arrays Market Size, By Region, 2014–2021 (USD Million)
Table 15 MALDI-TOF Market Size, By Region, 2014–2021 (USD Million)
Table 16 Mass Spectrometry Market Size, By Region, 2014–2021 (USD Million)
Table 17 Other Glycomics Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 18 Glycomics Kits Market Size, By Type, 2014-2021 (USD Million)
Table 19 Glycomics Kits Market Size, By Region, 2014-2021 (USD Million)
Table 20 Glycan Labeling Kits Market Size, By Region, 2014–2021 (USD Million)
Table 21 Glycan Purification Kits Market Size, By Region, 2014–2021 (USD Million)
Table 22 Glycan Release Kits Market Size, By Region, 2014–2021 (USD Million)
Table 23 Other Glycobiology Kits Market Size, By Region, 2014-2021 (USD Million)
Table 24 Glycobiology Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 25 Glycobiology Reagents Market Size, By Region, 2014-2021 (USD Million)
Table 26 Glycoproteins Market Size, By Region, 2014–2021 (USD Million)
Table 27 Monosaccharides Market Size, By Region, 2014–2021 (USD Million)
Table 28 Oligosaccharides Market Size, By Region, 2014–2021 (USD Million)
Table 29 Other Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 30 Glycomics Market Size, By Application, 2014–2021 (USD Million)
Table 31 Glycomics Market Size for Diagnostics, By Region, 2014–2021 (USD Million)
Table 32 Glycomics Market Size for Drug Discovery and Development, By Region, 2014–2021 (USD Million)
Table 33 Glycomics Market Size for Oncology, By Region, 2014–2021 (USD Million)
Table 34 Glycomics Market Size for Immunology, By Region, 2014–2021 (USD Million)
Table 35 Glycomics Market Size for Other Applications, By Region, 2014–2021 (USD Million)
Table 36 Glycomics Market Size, By End User, 2014–2021 (USD Million)
Table 37 Glycomics Market Size for Academic Research Institutes, By Region, 2014–2021 (USD Million)
Table 38 Glycomics Market Size for Pharmaceutical & Biotechnology Companies, By Region, 2014–2021 (USD Million)
Table 39 Glycomics Market Size for Contract Research Organizations, By Region, 2014–2021 (USD Million)
Table 40 Glycomics Market Size, By Region, 2014–2021 (USD Million)
Table 41 North America: Glycomics Market Size, By Country, 2014–2021 (USD Million)
Table 42 North America: Glycomics Market Size, By End User, 2014–2021 (USD Million)
Table 43 North America: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 44 North America: Glycomics Enzymes Market Size, By Type, 2014–2021 (USD Million)
Table 45 North America: Glycomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 46 North America: Glycobiology Kits Market Size, By Type, 2014–2021 (USD Million)
Table 47 North America: Glycobiology Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 48 North America: Glycobiology Market Size, By Application, 2014–2021 (USD Million)
Table 49 U.S.: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 50 Canada: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 51 Europe: Glycomics Market Size, By Country, 2014–2021 (USD Million)
Table 52 Europe: Glycomics Market Size, By End User, 2014–2021 (USD Million)
Table 53 Europe: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 54 Europe: Glycomics Enzymes Market Size, By Type, 2014–2021 (USD Million)
Table 55 Europe: Glycobiology Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 56 Europe: Glycobiology Kits Market Size, By Type, 2014–2021 (USD Million)
Table 57 Europe: Glycobiology Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 58 Europe: Glycomics Market Size, By Application, 2014–2021 (USD Million)
Table 59 Germany: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 60 France: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 61 U.K.: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 62 Italy: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 63 Spain: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 64 RoE: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 65 Asia: Glycomics Market Size, By Country, 2014–2021 (USD Million)
Table 66 Asia: Glycomics Market Size, By End User, 2014–2021 (USD Million)
Table 67 Asia: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 68 Asia: Glycomics Enzymes Market Size, By Type, 2014–2021 (USD Million)
Table 69 Asia: Glycomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 70 Asia: Glycomics Kits Market Size, By Type, 2014–2021 (USD Million)
Table 71 Asia: Glycomics Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 72 Asia: Glycomics Market Size, By Application, 2014–2021 (USD Million)
Table 73 China: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 74 Japan: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 75 India: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 76 Roa: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 77 RoW: Glycomics Market Size, By Region, 2014–2021 (USD Million)
Table 78 RoW: Glycomics Market Size, By End User, 2014–2021 (USD Million)
Table 79 RoW: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 80 RoW: Glycomics Enzymes Market Size, By Type, 2014–2021 (USD Million)
Table 81 RoW: Glycomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 82 RoW: Glycomics Kits Market Size, By Type, 2014–2021 (USD Million)
Table 83 RoW: Glycomics Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 84 RoW: Glycobiology Market Size, By Application, 2014–2021 (USD Million)
Table 85 South America: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 86 Middle East and Africa: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 87 Pacific and Oceania: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 88 Product Launches, 2013–2016
Table 89 Expansions, 2013-2016
Table 90 Agreements, 2013–2016
Table 91 Acquisitions, Collaborations, Approvals, and Others, 2013–2016
 
 
List of Figures (32 Figures)
 
Figure 1 Global Glycomics Market
Figure 2 Research Methodology
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Break Down of Primary Interviews: By Company Type, Designation, & Region
Figure 6 Data Triangulation Methodology
Figure 7 Enzymes to Register the Highest CAGR Between 2016 & 2021
Figure 8 Glycosidases to Dominate the Glycomics Enzymes Market in 2016
Figure 9 Mass Spectrometry to Grow at the Highest Rate During the Forecast Period
Figure 10 Glycan Release Kits to Dominate the Glycomics Kits Market in 2016
Figure 11 Oligosaccharides to Command the Largest Share of the Glycomics Reagents Market in 2016
Figure 12 Increasing Funding in Glycomics and Proteomics Research to Drive the North American Glycomics Market
Figure 13 Increasing Funding for Proteomics & Glycomics Research is an Important Growth Driver for the Glycomics Market
Figure 14 Enzymes to Account for the Largest Product Segment of the Glycomics Market in 2016
Figure 15 Asia to Register the Highest CAGR During the Forecast Period
Figure 16 Asia Holds Lucrative Growth Opportunities for Glycomics Products During the Forecast Period
Figure 17 Increasing Government and Private Funding for Proteomics and Glycobiology Research to Drive the Demand for Glycobiology Products
Figure 18 Glycomics Market in Asia to Register Highest Growth During the Forecast
Figure 19 North America: Glycomics Market Snapshot
Figure 20 Asia: Glycomics Market Snapshot
Figure 21 Key Developments in the Global Glycomics Market, 2013–2016
Figure 22 Global Glycomics Enzymes, Kits, and Reagents Market Share Analysis, By Key Player, 2015
Figure 23 Battle for Market Share: Product Launches is the Key Strategy Adopted By Players in the Glycomics Market Between 2013 & 2016
Figure 24 Geographic Revenue Mix of Top 5 Market Players
Figure 25 Merck KGaA: Company Snapshot (2015)
Figure 26 Takara Bio, Inc.: Company Snapshot (2015)
Figure 27 Shimadzu Corporation: Company Snapshot (2015)
Figure 28 Bruker Corporation: Company Snapshot (2015)
Figure 29 Waters Corporation: Company Snapshot (2015)
Figure 30 Agilent Technologies, Inc.: Company Snapshot (2015)
Figure 31 Danaher Corporation Company Snapshot (2015)
Figure 32 Thermo Fisher Scientific, Inc.: Company Snapshot (2015)

The global glycomics market is poised to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, at a CAGR of 13.3%. Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the market. Whereas, the high degree of consolidation is expected to restrict the entry of new players in the market, and thereby hinder its growth.

On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. The enzymes segment is projected to grow at the highest CAGR during the forecast period. This growth is mainly attributed to their consumable nature and wide applications in a variety of R&D and drug discovery procedures. The enzymes segment is further divided into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes.

On the basis of application, the market is segmented into diagnostics, drug discovery & development, oncology, immunology, and other applications. In 2016, the drug discovery and development segment is expected to account for the largest share of the market. This growth can be attributed to increase in R&D activities for the development of novel drugs and therapies.

On the basis of end user, the glycomics market is segmented into academic research institutes, pharmaceutical & biotechnology companies, and CROs. In 2016, the academic research institutes segment is projected to account for the largest share of the market. This growth can be attributed to the increasing government and private funding for proteomic and glycomics research.

On the basis of region, the market is segmented into North America, Asia, Europe, and RoW. The Asian market is estimated to grow at the highest CAGR during the forecast period. This growth is mainly attributed to the increasing commercialization of R&D by pharmaceutical and biotechnology companies, growing demand for personalized medicine, and rising importance of companion diagnostics.

Glycobiology / Glycomics Market

In 2015, the global glycomics market was dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Over the next five years, the growth of the glycobiology market in the Asian region is likely to be centered on China, India, and Japan.

The key players in the glycomics market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo